HRT Financial’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,700
Closed -$273K 4633
2025
Q4
$273K Sell
17,700
-68,269
-79% -$1.25M ﹤0.01% 2431
2025
Q3
$1.86M Buy
+85,969
New +$1.92M 0.01% 1179
2025
Q2
Sell
-35,278
Closed -$837K 3429
2025
Q1
$837K Buy
35,278
+21,203
+151% +$502K 0.01% 1200
2024
Q4
$297K Sell
14,075
-6,864
-33% -$180K ﹤0.01% 1725
2024
Q3
$675K Buy
+20,939
New +$618K ﹤0.01% 1446
2024
Q1
Sell
-17,853
Closed -$571K 3006
2023
Q4
$571K Sell
17,853
-33,689
-65% -$978K ﹤0.01% 1288
2023
Q3
$1.51M Buy
+51,542
New +$1.85M 0.02% 757
2022
Q4
Sell
-52,879
Closed -$1.24M 3060
2022
Q3
$1.24M Buy
52,879
+70
+0.1% +$2.23K 0.01% 794
2022
Q2
$1.53M Buy
+52,809
New +$2.31M 0.02% 687
2021
Q4
Sell
-39,792
Closed -$1.68M 3981
2021
Q3
$1.68M Buy
+39,792
New +$2.03M 0.01% 852

Other funds holding SGRY

HRT Financial's SGRY Position: Q1 2026 in Review

HRT Financial sold out of Surgery Partners (SGRY) in Q1 2026, closing a stake of 17,700 shares — an estimated $273K sold.

HRT Financial first reported a position in SGRY in Q3 2021 and held it in 10 quarters. The position peaked at $1.86M in Q3 2025. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • HRT Financial reported no remaining Surgery Partners position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 17,700 Surgery Partners shares in Q1 2026, an estimated $273K.
  • HRT Financial first reported a position in Surgery Partners in Q3 2021 and held it in 10 quarters.
  • HRT Financial's Surgery Partners position peaked at $1.86M in Q3 2025.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.